Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Briony Shaw

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
Hematologic Malignancy: Who Cares in the End? A Retrospective Cohort Study of Markers of Quality End-of-Life CareBriony Shaw, Catriona Parker, Stephen Opat, et al.
Transfusion Medicine Reviews|July 2, 2022
Home Delivery: Transfusion Services When and Where They Are NeededBriony Shaw, Erica M Wood, Jeannie Callum, et al.
Access Microbiology|September 25, 2020
Persistently positive culture of antimicrobial-susceptible <i>Legionella pneumophila</i> despite appropriate therapyNastaran Rafiei, Briony Shaw, Claire Dendle, et al.
European Journal of Haematology|April 8, 2021
Risk factors for invasive fungal infection in 5-azacytidine treated patients with acute myeloid leukemia and myelodysplastic syndromeAmanda Tey, Briony Shaw, Luke Cardamone, et al.
Internal Medicine Journal|November 27, 2022
Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2Briony Shaw, Jake Shortt, Michael Low, et al.
British Journal of Haematology|March 3, 2023
Outcomes of human immunodeficiency virus-associated Burkitt lymphoma and diffuse large B-cell lymphoma treated in Australia: A report from the Australasian Lymphoma AllianceKenneth J C Lim, Pietro Di Ciaccio, Mark N Polizzotto, et al.
Internal Medicine Journal|May 23, 2025
Frailty and geriatric assessments in older patients diagnosed with acute myeloid leukaemia: an Australasian Leukaemia and Lymphoma Group consensus statementBriony Shaw, Victoria Yee-May Ling, Ruth E Hubbard, et al.
Ejhaem|April 18, 2024
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry projectBriony Shaw, Eliza Chung, Cameron Wellard, et al.
Ejhaem|August 19, 2024
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma AllianceMaciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, et al.
Haematologica|February 23, 2023
Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma AllianceAllison Barraclough, James T England, Diego Villa, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
Hematologic Malignancy: Who Cares in the End? A Retrospective Cohort Study of Markers of Quality End-of-Life CareBriony Shaw, Catriona Parker, Stephen Opat, et al.
Transfusion Medicine Reviews|July 2, 2022
Home Delivery: Transfusion Services When and Where They Are NeededBriony Shaw, Erica M Wood, Jeannie Callum, et al.
Access Microbiology|September 25, 2020
Persistently positive culture of antimicrobial-susceptible <i>Legionella pneumophila</i> despite appropriate therapyNastaran Rafiei, Briony Shaw, Claire Dendle, et al.
European Journal of Haematology|April 8, 2021
Risk factors for invasive fungal infection in 5-azacytidine treated patients with acute myeloid leukemia and myelodysplastic syndromeAmanda Tey, Briony Shaw, Luke Cardamone, et al.
Internal Medicine Journal|November 27, 2022
Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2Briony Shaw, Jake Shortt, Michael Low, et al.
British Journal of Haematology|March 3, 2023
Outcomes of human immunodeficiency virus-associated Burkitt lymphoma and diffuse large B-cell lymphoma treated in Australia: A report from the Australasian Lymphoma AllianceKenneth J C Lim, Pietro Di Ciaccio, Mark N Polizzotto, et al.
Internal Medicine Journal|May 23, 2025
Frailty and geriatric assessments in older patients diagnosed with acute myeloid leukaemia: an Australasian Leukaemia and Lymphoma Group consensus statementBriony Shaw, Victoria Yee-May Ling, Ruth E Hubbard, et al.
Ejhaem|April 18, 2024
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry projectBriony Shaw, Eliza Chung, Cameron Wellard, et al.
Ejhaem|August 19, 2024
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma AllianceMaciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, et al.
Haematologica|February 23, 2023
Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma AllianceAllison Barraclough, James T England, Diego Villa, et al.
Pageof 1